Since its inception in 2018, the Centre has emerged as a leading hub for comprehensive and accessible cancer treatment, having treated nearly 65,000 patients, performed close to 12,000 major surgeries, and delivered over 80,000 chemotherapy sessions.
For many adults recovering from cancer, finishing treatment does not mean the end of challenges. Subtle but disruptive changes in memory, attention, and mental processing--often called "chemobrain"--can make work, relationships, and everyday routines unexpectedly difficult.
Raichur (Karnataka) [India], November 11: Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED) announced the successful completion of its fourth complex clinical program SMLINJ011, with positive topline Phase 3 results for Shilpa's OERIS™ (Ondansetron Extended-Release Injection)--an innova
Hyderabad (Telangana) [India], September 25: In a landmark initiative to expand affordable breast cancer treatment in India, Hetero Healthcare Limited has announced the launch of Perzea, its most cost-effective biosimilar of Pertuzumab. Developed through a semi-exclusive collaboration with E
New Delhi [India], September 22: Cancer treatment has transformed significantly over the years and is moving beyond a generic and uniform approach. Although chemotherapy was the foundation of cancer treatment for decades, the development of immunotherapy has created new opportunities for doc
A 35-year-old woman, five months pregnant, was diagnosed with triple-positive breast cancer in July 2024, highlighting the complexities of treating cancer during pregnancy.
Gurugram (Haryana) [India]/ Wilmington (Delaware) [US], August 19: The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today an
Ahmedabad (Gujarat) [India], August 6: Intas Pharmaceuticals has launched HETRONIFLY™ (Serplulimab), the first PD-1 inhibitor globally approved for the treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC), in the Indian market. This marks another major milestone, following the
Kolkata (West Bengal) [India], July 28: In a landmark achievement, a 60-year-old woman with advanced primary peritoneal carcinomatosis was successfully treated with Cytoreductive Surgery (CRS) combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at Manipal Hospital Dhakuria, under
Cleveland Clinic Abu Dhabi has successfully performed the UAE's first robotic cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) to treat a rare appendiceal tumour, in a medical milestone that reinforces Abu Dhabi's position as a global destination for innovative he